In SCLC, INSM1 expression is recognized as a highly sensitive and specific nuclear marker of NE differentiation and has been linked to increased sensitivity to chemotherapy agents like irinotecan (25). The gene discussed is INSM1; the disease is small cell lung carcinoma.